The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 6
- 6 new
- Median first-year cost
- $580,078
- $3,402,726 in all
- Institutions
- 6
- 6 contact PIs
- Patents
- 2
- from 2 funded projects
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- H. LEE MOFFITT CANCER CTR & RES INST1
- INDIANA UNIVERSITY INDIANAPOLIS1
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
and 1 other institution
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-P (A1))3
- Special Emphasis Panel (ZCA1 RPRB-M (J1))3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | (PQC3) Ethnicity-determined immune response and DCIS outcome1R01CA194600-01 | Badve, Sunil S.Gerdes, Michael | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $707,173 | Study section ZCA1 |
| FY2015 | (PQC2) Localization as a determinant of cancer dormancy1R01CA194596-01 | Lin, Charles P.Scadden, David T | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $547,017 | Study section ZCA1 |
| FY2015 | (PQC1) Accelerated biological aging and colon polyp to cancer progression1R01CA194663-01 | Grady, William Mallory | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | First-year cost $420,546 | Study section ZCA1 |
| FY2014 | (PQC4) Habitats in Prostate Cancer1R01CA190105-01 | Gillies, Robert J.Pollack, Alan | H. LEE MOFFITT CANCER CTR & RES INST, FL | First-year cost $730,977 | Study section ZCA1 |
| FY2014 | (PQC-1) Driver Events In IBD-Associated Neoplastic Progression1R01CA190040-01 | Meltzer, Stephen JSelaru, Florin | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $613,138 | Study section ZCA1 |
| FY2014 | (PQC2) Plasticity Of The.PI3K Network In Early Dormancy1R01CA190027-01 | Altieri, Dario C | WISTAR INSTITUTE, PA | First-year cost $383,875 | Study section ZCA1 |
Patents from its funded projects
2 patents name 2 of the 6 funded projects.
- US 12,453,786 (opens the patent at USPTO, a PDF, in a new tab)RADIOMICS-BASED TREATMENT DECISION SUPPORT FOR LUNG CANCERGranted October 28, 2025 to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.R01CA190105 · H. LEE MOFFITT CANCER CTR & RES INST, FL
- US 11,208,478 (opens the patent at USPTO, a PDF, in a new tab)Methods of Detecting and Treating a Tumor Expressing PT346 PDK1Granted December 28, 2021 to The Wistar Institute of Anatomy and BiologyR01CA190027 · WISTAR INSTITUTE, PA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.